Canaccord Genuity Maintains Buy on CareDx, Raises Price Target to $80

Benzinga · 3d ago
Canaccord Genuity analyst Kyle Mikson maintains CareDx (NASDAQ:CDNA) with a Buy and raises the price target from $65 to $80.